← Leaderboards
Patricia Simner
Johns Hopkins University
$449,407
Attributed
$449,407
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $285.8K · FY2017–18$500K$375K$250K$125K$0
'17
'18
Funding mix
By agency
NIH$449,407 · 1
By mechanism
R21$449,407 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Craig A Townsend$23,597,395
- Kathleen H Burns$11,830,554
- Gyanu Lamichhane$9,492,958
- Petros C Karakousis$19,415,784
- Eric L Nuermberger$20,859,483
Others in their field
Other Emerging Leaders on “Antibiotic Resistance”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$25,064,821
- Bruce Blough · Research Triangle Institute$19,880,022
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Terry Roemer · Prokaryotics, Inc.$13,917,276
Research focus
Antibiotic ResistanceAntibioticsAntibiotic SusceptibilityBeta-LactamsBioinformaticsBiomedical EngineeringCarbapenemaseCarbapenemsCessation Of LifeChromosomesClinically SignificantClinical MicrobiologyCommunicable DiseasesComplexData AnalysesDatabasesDisease OutbreaksDna Insertion ElementsEnterobacteriaceaeEnzymesEpidemiologyExperimental StudyExtensive Drug ResistanceAcinetobacter
Grant awards (2)
Real-Time Whole Genome Sequencing Analysis of Carbapenemase-Producing Organisms in the Non-Outbreak Hospital Setting$163,646
R21 · FY2018 · AI · contact PI
Real-Time Whole Genome Sequencing Analysis of Carbapenemase-Producing Organisms in the Non-Outbreak Hospital Setting$285,761
R21 · FY2017 · AI · contact PI